Germany-based Merck KGaA plans to invest an additional $47 million to build a robust manufacturing and distribution platform in Asia over a span of two years.
The drugmaker has announced the following plans:
Manufacturing & distribution center in Songdo, South Korea:
The company’s new manufacturing and distribution center, located in the Songdo district of Incheon, will include an infrastructure to facilitate the supply of its products to customers in Korea and advanced cell culture media manufacturing capabilities. Occupying a land area of 109,000 square feet, the new site is expected to be fully operational in Q4 2019.
Manufacturing & distribution center in Mumbai, India:
The new manufacturing and distribution center, located in Mumbai, is expected to be completed in 2019. Occupying 10 acres, the site is more than 129,000 square feet with added capacity to meet future growth, further improving inventory availability.
Investment in Single-use Manufacturing in Wuxi, China:
This investment in Millipore Sigma Mobius single-use products and solutions addresses the growing biopharmaceutical demand in China. The site will be ready in 2018, and is expected to reduce lead time by at least 50 percent.
These recent investment plans follow the company’s November 2016 announcement of its $95 million Life Science investment in Nantong, China.
Read the press release
